Stock Movers

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Oracle (ORCL) shares extended their rebound on Monday, as ramped up capex spending by US technology giants helped soothe nerves over the threat posed to the company by developments in artificial intelligence. Shares in the software bellwether rallied as much as 12%, their biggest intraday rise since Sept. 10. Even with that move — which came on the heels of Amazon.com Inc.’s pledge to spend $200 billion this year on data centers, chips and other equipment — the stock is down around 50% from its September highs.
- Kroger (KR) shares jumped 3.9% after the supermarket operator appointed retail veteran Greg Foran as its chief executive officer.

- Workday (WDAY) shares are down 9% on Monday, after the software company said that co-founder and current Executive Chair Aneel Bhusri is returning as CEO, replacing Carl Eschenbach effective immediately.
See omnystudio.com/listener for privacy information.

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Matt Miller, Katie Greifeld, Carol Massar and Tim Stenovec

On this episode of Stock Movers:
- Applovin (APP) stock surged Monday after a financial publisher retracted some of its most explosive claims regarding AppLovin's alleged connections to transnational crime syndicates.
Capitalwatch, a self-described independent news organization and publisher, accused AppLovin of serving as a "laundering machine" for illicit funds from Southeast Asia. It described major shareholder Hao Tang as the key facilitator of this scheme.
- Oracle (ORCL) shares extended their rebound on Monday, as ramped up capex spending by US technology giants helped soothe nerves over the threat posed to the company by developments in artificial intelligence. Shares in the software bellwether rallied as much as 12%, their biggest intraday rise since Sept. 10. Even with that move — which came on the heels of Amazon.com Inc.’s pledge to spend $200 billion this year on data centers, chips and other equipment — the stock is down around 50% from its September highs.
- Hims & Hers Health (HIMS) stocks fell after Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:
- Oracle (ORCL) shares extended their rebound on Monday, as ramped up capex spending by US technology giants helped soothe nerves over the threat posed to the company by developments in artificial intelligence. Shares in the software bellwether rallied as much as 12%, their biggest intraday rise since Sept. 10. Even with that move — which came on the heels of Amazon.com Inc.’s pledge to spend $200 billion this year on data centers, chips and other equipment — the stock is down around 50% from its September highs.
- Kyndryl (KD) shares plunged Monday morning after the company announced key leadership exits and a review of its accounting practices. The stock fell a record 57% before being briefly halted for volatility on news that Kyndryl Chief Financial Officer David Wyshner had left the position and that General Counsel Edward Sebold departed the post, effective immediately. On the same date, Vineet Khurana stepped down as senior vice president and global controller of the company and moved to a different role.
- Hims & Hers Health (HIMS) stock plummeted Monday after Novo Nordisk filed a lawsuit, claiming the online pharmacy is "deceiving patients" with its compounded diabetes and weight-loss drugs.
But it's still not clear that Novo Nordisk will ultimately win out against Hims & Hers Health, Leerink Partners analyst David Risinger said in a report.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Hims & Hers (HIMS) shares fall on news that Novo Nordisk is suing the company for making knock-offs of its obesity medicines, including a copycat version of the Wegovy pill. The lawsuit targets not only Hims's copycat pill but also shots that mimic Novo's Wegovy and Ozempic, with Novo arguing that Hims's products are putting patient health and wellbeing at risk.

- Kroger (KR) shares rise after the company named Greg Foran its chief executive officer as the nation’s largest supermarket operator seeks to reset after a failed mega-merger and the sudden exit of its former leader.

- Monday.com (MNDY) shares sink after the software company’s revenue forecast was weaker than expected. According to Bloomberg Intelligence: Monday.com's below-consensus 2026 outlook reinforces our caution around seat-based business models amid slower AI-feature monetization, a shift toward agentic workflows and newer product rollouts from foundational model providers that increase the risk of disintermediation.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:

- Alphabet Inc.(GOOGL) is tapping the US high-grade bond market, adding to a borrowing spree by companies at the forefront of the artificial intelligence investment boom.

- Hims & Hers Health (HIMS) tumbles 20% after the telehealth company said it will stop selling its recently launched copycat version of the new Wegovy weight-loss pill.

- Tegna Inc.(TGNA) rises 9% after President Donald Trump backed television broadcaster Nexstar Media Group’s proposed $3.5 billion acquisition of the company.
See omnystudio.com/listener for privacy information.